drugset
drugset / Trial / NCT04350450

Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore

NCT04350450 ↗

Phase 2 Withdrawn Montefiore Medical Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Given the high prevalence of COVID19 illness (both SARS-CoV-2 RT-PCR confirmed and highly suspect cases) among healthcare workers (HCW) within the Montefiore Health System (MHS), hydroxychloroquine (HCQ) will be prescribed to healthcare workers who are at the highest risk for severe COVID19 illness.

Timeline

Start
2020-04
Primary completion
2020-08
Completion
2020-08

Outcome

Outcome not reported

Stopped: “PI withdrew the submission to the IRB”

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule 400 mg —

Indications

COVID-19